FDA inspection
Ajanta Pharma Ltd.: FDA inspection ending Apr 21, 2026
FDA inspection 1313426 · Voluntary Action Indicated (VAI) · Paithan
Key facts
| Inspection ID | 1313426 |
|---|---|
| Firm | Ajanta Pharma Ltd. |
| FEI number | 3006785788 |
| Address | B-4/5/6 Midc Industrial Area, District - Aurangabad |
| City | Paithan |
| Country | India |
| Fiscal year | 2026 |
| Inspection end date | Apr 21, 2026 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data